Ulrich Naher - 29 Jan 2022 Form 4/A - Amendment Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP, Chief Commercial Officer
Signature
Jonathan B. Leiken, Attorney in fact for Ulrich Naeher
Issuer symbol
DBD
Transactions as of
29 Jan 2022
Net transactions value
-$182,952
Form type
4/A - Amendment
Filing time
07 Feb 2022, 15:07:50 UTC
Date Of Original Report
31 Jan 2022
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability $140,642 -15,982 -7% $8.80* 210,871 29 Jan 2022 Direct F1, F2
transaction DBD Common Shares Tax liability $42,310 -4,808 -2.3% $8.80* 206,063 30 Jan 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Options 49,650 29 Jan 2022 Common Shares 49,650 $26.60 Direct F3
holding DBD Non-Qualified Stock Option 30,278 29 Jan 2022 Common Shares 30,278 $18.75 Direct F4
holding DBD Non-Qualified Stock Option 47,407 29 Jan 2022 Common Shares 47,407 $4.08 Direct F4
holding DBD Non-Qualified Stock Option 12,614 29 Jan 2022 Common Shares 12,614 $11.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.